You searched for: diazabicyclo (Engelska - Tyska)

diazabicyclo(3.3.1)nonanes.
diazabicyclo-(3,3,1)-nonane.

diazabicyclo derivatives as 5-ht3 antagonists.
diazabicycloderivate als 5-ht3-antagonisten.

diazabicyclo alkane derivatives with nk1 antagonistic activity
diazabicycloalkan-derivate mit nk1-antagonistischer wirkung

heteroaryl-diazabicyclo-alkanes as cns-modulators
heteroaryl-diazabicycloalkanderivaten als cns-modulatoren

preparation of 1,4-diazabicyclo [3.2.2]nonane.
herstellung von 1,4-diazabicyclo[3.2.2]nonanen.

1,4-diazabicyclo[2.2.2]octane (triethylenediamine)
1,4-diazabicyclo[2.2.2]octan (triethylenediamin)

diazabicyclo(2,2,2)octadiones and process for their preparation.
diazabicyclo(2.2.2.)octadione und verfahren zu ihrer herstellung.

ethyl-2,5-diazabicyclo[2.2.1]heptane dihydrobromide
ethyl-2,5-diazabicyclo[2.2.1]heptandihydrobromid

1,9-diazabicyclo 4.3.0]nona-3,8-diene derivatives
1,9-diazabicyclo(4.3.0)nona-3,8)dienderivate

anti-arrhythmic 3,7-diazabicyclo (3,3,1)nonane compounds
anti-arrhythmische 3,7-diazabicyclo(3,3,1)nonan-verbindungen

1,4-diazabicyclo 3.2.2 nonanecarboxamide derivatives, preparation and therapeutic use thereof
1,4-diazabicyclo¬3.2.2 nonanecarboxamides derivate, deren herstellung, und deren therapeutische verwendung im zusammenhang mit nicotinische rezeptoren stÖrungen

process for the preparation of 1,4-diazabicyclo(2,2,2)-octanes.
verfahren zur herstellung von 1,4-diazabicyclo(2,2,2)-octanen.

pharmaceutical compositions containing 3-phenylsulfonyl-3,7-diazabicyclo 3,3,1 nonanes.
neue 3-phenylsulfonyl-3,7-diazabicyclo(3,3,1)nonan-verbindungen enthaltende arzneimittel.

1,4-diazabicyclo(3,2,2)nonane derivatives, preparation and therapeutical use thereof
1,4-dizabicyclo(3,2,2)nonane derivative, verfahren zur ihre herstellung und therapeutical verwendung

(1s)-2-methyl-2,5-diazabicyclo[2.2.1]heptane dihydrobromide
(1s)-2-methyl-2,5-diazabicyclo[2.2.1]heptandihydrobromid

3,9-diazabicyclo(3.3.1)nonane derivatives with 5-ht3 receptor antagonist activity.
3,9- diazabicyclo (3,3,1) nonanderivate mit 5-ht3 rezeptor antagonistischer wirkung.

process for optically active 2-alkyl-2,5-diazabicyclo[2.2.1]heptanes.
verfahren zur herstellung von optisch aktiven 2-alkyl-2,5-diazabicyclo[2.2.1]heptanen.

1,8-diazabicyclo-[5,4,0]-undec-7-ene (dbu) is particularly preferred.
1,8-diazabicyclo-[5.4.0]-undec-7-en (dbu) wird besonders bevorzugt.

(1s,5s)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
(1s,5s)-3-(5,6-dichlorpyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptanbenzolsulfonat